Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06307275 · ClinicalTrials.gov registry record · NA

Intermittent Fasting on Body Fat and Quality of Life

A NA study of Healthy, sponsored by Loma Linda University.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06307275: Recruiting NA study of Healthy, sponsored by Loma Linda University.

NCT06307275 is a NA study of Healthy that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 70 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06307275, a NA study of Healthy, is actively recruiting participants, sponsored by Loma Linda University.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this investigator-initiated study to check the feasibility that intermittent fasting has on body fat loss and quality of life.

Primary Outcome

Body composition will give the following measurement: body fat percentage

Conditions Studied

Interventions

  • OTHER Fasting
  • OTHER non fasting

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-03-11
Est. Completion 2025-12
Phase NA
Loma Linda University

237 total trials

What NCT06307275 shows while recruiting

NCT06307275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Fasting is the first listed.

NCT06307275 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06307275 about?

NCT06307275 is a clinical study titled "Intermittent Fasting on Body Fat and Quality of Life". The purpose of this investigator-initiated study to check the feasibility that intermittent fasting has on body fat loss and quality of life.

What is the current status of trial NCT06307275?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-03-11. Estimated completion is 2025-12.

What conditions does trial NCT06307275 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06307275?

The interventions under investigation include: Fasting (OTHER), non fasting (OTHER).

Who is sponsoring clinical trial NCT06307275?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06307275 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06307275's enrollment target sits among peer trials

70 325th of 1090 higher than 759 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06307275, the US trial registry maintained by the National Library of Medicine. NCT06307275 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.